No headlines found.
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
PRNewswire (Wed, 31-Dec 4:30 PM ET)
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES CHANGES TO PORTFOLIO MANAGEMENT TEAM
PRNewswire (Mon, 15-Dec 4:55 PM ET)
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
PRNewswire (Fri, 28-Nov 4:30 PM ET)
NHS invests in the high yield debt securities markets. At least 80% of the Fund will be invested in below investment grade (high yield) debt securities (including corporate loans) of US and foreign issuers. The Fund may invest up to 20% of its managed assets in other securities. The Fund will attempt to maintain an average (dollar-weighted) portfolio quality of B/B to Ba/BB, with less than 20% of the Fund’s portfolio composed of securities rated Caa/CCC or lower. The fund can utilize leverage through the issuance of preferred stock, privately placed notes and privately placed perpetual preferred shares.
Neuberger Berman High Yield St trades on the AMEX stock market under the symbol NHS.
As of January 29, 2026, NHS stock price climbed to $7.60 with 185,747 million shares trading.
NHS has a beta of 0.27, meaning it tends to be less sensitive to market movements. NHS has a correlation of 0.12 to the broad based SPY ETF.
NHS has a market cap of $238.25 million. This is considered a Small Cap stock.
In the last 3 years, NHS traded as high as $9.40 and as low as $6.62.
NHS has underperformed the market in the last year with a return of +14.4%, while SPY returned +16.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NHS shares. However, NHS has outperformed the market in the last 3 month and 2 week periods, returning +5.2% and +4.5%, while SPY returned +1.3% and +0.5%, respectively. This indicates NHS has been having a stronger performance recently.
NHS support price is $7.50 and resistance is $7.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NHS shares will trade within this expected range on the day.